• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

磷酸盐潴留在肾衰竭进展中的作用。

Role of phosphate retention in the progression of renal failure.

作者信息

Loghman-Adham M

机构信息

Department of Pediatrics, University of Utah School of Medicine, Salt Lake City.

出版信息

J Lab Clin Med. 1993 Jul;122(1):16-26.

PMID:8320487
Abstract

Dietary phosphorus restriction can prevent the progression of renal failure in subtotally nephrectomized rats or in rats with nephrotoxic serum nephritis, independent of protein and caloric intake. Conversely, diets high in phosphorus content result in a more rapid deterioration of renal function. The results are less compelling in indicating that phosphorus restriction can slow the progression of renal failure in the clinical setting. The toxicity of phosphate appears to be related to induction of calcium phosphate precipitation, resulting in tubulointerstitial disease. Most studies of prevention of renal calcification have addressed a single pathway in the development of nephrocalcinosis. These include inhibitors of calcium phosphate precipitation, calcium channel blockers, or an inhibitor of PTH secretion. All of these studies have shown a beneficial effect in preserving renal function. It is possible that a combination of these agents, started early in the course of CRF, may have an additive effect in preventing the progression to ESRD. The discussion of other factors associated with progression of renal failure is beyond the scope of this review. It is obvious that dietary protein restriction, treatment of systemic and intraglomerular hypertension and lipid abnormalities, and prevention of iron overload, all play roles in the preservation of renal function in CRF.

摘要

饮食中限制磷的摄入可以预防肾大部切除大鼠或患有肾毒性血清性肾炎大鼠的肾衰竭进展,这与蛋白质和热量摄入无关。相反,高磷饮食会导致肾功能更快恶化。在临床环境中,关于磷限制能减缓肾衰竭进展的证据并不那么令人信服。磷酸盐的毒性似乎与磷酸钙沉淀的诱导有关,从而导致肾小管间质疾病。大多数预防肾钙化的研究都针对肾钙质沉着症发展过程中的单一途径。这些途径包括磷酸钙沉淀抑制剂、钙通道阻滞剂或甲状旁腺激素分泌抑制剂。所有这些研究都表明在保护肾功能方面有有益作用。在慢性肾衰竭病程早期开始联合使用这些药物,可能对预防进展为终末期肾病有相加作用。本文综述范围不涉及与肾衰竭进展相关的其他因素的讨论。显然,饮食中限制蛋白质摄入、治疗全身性和肾小球内高血压及脂质异常以及预防铁过载,在慢性肾衰竭患者肾功能的保护中均发挥作用。

相似文献

1
Role of phosphate retention in the progression of renal failure.磷酸盐潴留在肾衰竭进展中的作用。
J Lab Clin Med. 1993 Jul;122(1):16-26.
2
[Effect of PTH, phosphate, and metabolic acidosis on the progression of renal insufficiency in the azotemic rat].[甲状旁腺激素、磷酸盐及代谢性酸中毒对氮质血症大鼠肾功能不全进展的影响]
Nefrologia. 2003;23 Suppl 2:37-42.
3
Sevelamer hydrochloride, a phosphate binder, protects against deterioration of renal function in rats with progressive chronic renal insufficiency.盐酸司维拉姆是一种磷结合剂,可防止进行性慢性肾功能不全大鼠的肾功能恶化。
Nephrol Dial Transplant. 2003 Oct;18(10):2014-23. doi: 10.1093/ndt/gfg309.
4
1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.1α(OH)D3 一α-羟基胆钙化醇——一种活性维生素 D 类似物。关于慢性透析的尿毒症患者继发性甲状旁腺功能亢进症预防和治疗的临床研究。
Dan Med Bull. 2008 Nov;55(4):186-210.
5
Effect of ammonium chloride and dietary phosphorus in the azotaemic rat. Part II--Kidney hypertrophy and calcium deposition.氯化铵和膳食磷对氮血症大鼠的影响。第二部分——肾肥大和钙沉积
Nephrol Dial Transplant. 2004 Aug;19(8):1993-8. doi: 10.1093/ndt/gfh301. Epub 2004 May 25.
6
The interaction of PTH and dietary phosphorus and calcium on serum calcitriol levels in the rat with experimental renal failure.甲状旁腺激素(PTH)与膳食磷和钙对实验性肾衰竭大鼠血清骨化三醇水平的相互作用。
Nephrol Dial Transplant. 1996 Aug;11(8):1553-8.
7
Nicotinamide prevents the development of hyperphosphataemia by suppressing intestinal sodium-dependent phosphate transporter in rats with adenine-induced renal failure.烟酰胺通过抑制腺嘌呤诱导的肾衰竭大鼠肠道钠依赖性磷酸盐转运体,预防高磷血症的发生。
Nephrol Dial Transplant. 2005 Jul;20(7):1378-84. doi: 10.1093/ndt/gfh781. Epub 2005 May 3.
8
[Control of calcium and phosphate metabolism and prevention of vascular calcifications in uremic patients].[尿毒症患者钙磷代谢的控制及血管钙化的预防]
G Ital Nefrol. 2005 Jan-Feb;22 Suppl 31:S47-52.
9
[Are all antihypertensive drugs renoprotective?].[所有抗高血压药物都具有肾脏保护作用吗?]
Herz. 2004 May;29(3):248-54. doi: 10.1007/s00059-003-2508-6.
10
Effect of ammonium chloride and dietary phosphorus in the azotaemic rat. I. Renal function and biochemical changes.氯化铵和膳食磷对氮血症大鼠的影响。I. 肾功能和生化变化。
Nephrol Dial Transplant. 2004 Aug;19(8):1986-92. doi: 10.1093/ndt/gfh311. Epub 2004 Jun 1.

引用本文的文献

1
Phosphate-Induced Renal Fibrosis Requires the Prolyl Isomerase Pin1.磷酸盐诱导的肾纤维化需要脯氨酰异构酶Pin1。
PLoS One. 2016 Feb 25;11(2):e0150093. doi: 10.1371/journal.pone.0150093. eCollection 2016.
2
The Envy of Scholars: Applying the Lessons of the Framingham Heart Study to the Prevention of Chronic Kidney Disease.学者们的羡慕:将弗雷明汉心脏研究的经验教训应用于慢性肾脏病的预防
Rambam Maimonides Med J. 2015 Jul 30;6(3):e0029. doi: 10.5041/RMMJ.10214.
3
Phosphate restriction significantly reduces mortality in uremic rats with established vascular calcification.
限制磷酸盐摄入可显著降低已发生血管钙化的尿毒症大鼠的死亡率。
Kidney Int. 2013 Dec;84(6):1145-53. doi: 10.1038/ki.2013.213. Epub 2013 Oct 9.
4
Metabolomic markers for intestinal ischemia in a mouse model.肠道缺血的代谢组学标志物在小鼠模型中的研究
J Surg Res. 2012 Dec;178(2):879-87. doi: 10.1016/j.jss.2012.08.011. Epub 2012 Aug 25.
5
Phosphate overload accelerates vascular aging in uremic patients.磷过载加速尿毒症患者血管衰老。
Heart Int. 2006;2(1):6. doi: 10.4081/hi.2006.6. Epub 2006 May 28.
6
Emerging risk factors and markers of chronic kidney disease progression.慢性肾脏病进展的新兴风险因素和标志物。
Nat Rev Nephrol. 2009 Dec;5(12):677-89. doi: 10.1038/nrneph.2009.173.
7
Safety of new phosphate binders for chronic renal failure.新型磷酸盐结合剂用于慢性肾衰竭的安全性
Drug Saf. 2003;26(15):1093-115. doi: 10.2165/00002018-200326150-00003.
8
[Therapy and prophylaxis of renal failure].[肾衰竭的治疗与预防]
Internist (Berl). 2003 Jul;44(7):819-24, 826-30. doi: 10.1007/s00108-003-0948-y.
9
Drug administration in patients with renal insufficiency. Minimising renal and extrarenal toxicity.肾功能不全患者的药物给药。将肾毒性和肾外毒性降至最低。
Drug Saf. 1997 Mar;16(3):205-31. doi: 10.2165/00002018-199716030-00005.